News

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the...

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan

If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the...

Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs

The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer...

Thanksgiving Wishes to the DEA’s Anti Cannabis Holdouts – And Gently Suggests They Spend a Moment Thinking About Patients Waiting for Legal Medicine

MMJ Wishes DEA Officials a Happy Thanksgiving - While Reminding Them That Huntington's Chorea Doesn't Take Holidays. WASHINGTON, D.C. /...

Internet of Behaviors Market Surges to USD 14.3 Billion by 2033, Propelled by 26.5% CAGR – Verified Market Reports®

Internet of Behaviors (IoB) market projection signals robust CAGR driven by exponential data proliferation, AI-driven behavioral analytics and cross-channel orchestration....

In-Silico Clinical Trials Market Set to Reach USD 6.39 Billion by 2033 as Pharma and MedTech Accelerate Digital-First Validation, AI Modeling & Virtual Patient Simulations

AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was...

AdvaHealth Solutions Unveils AdvaPACS, a Cloud-Native and AI-Forward Imaging Platform Built for Modern Radiology Workflows with No Upfront Costs and Flexible OpEx Pricing

A complete cloud imaging platform (PACS + VNA) designed for scalability, AI-enabled workflows, faster reporting, and operational efficiency, without infrastructure,...

error: Content is protected !!